Michel, M., Hollenbach, M., Pohl, S., Ripoll, C., & Zipprich, A. (2019). Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma. Front Oncol.
Chicago-stil citatMichel, Maurice, Marcus Hollenbach, Sabine Pohl, Cristina Ripoll, och Alexander Zipprich. "Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma." Front Oncol 2019.
MLA-referensMichel, Maurice, et al. "Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma." Front Oncol 2019.